OPINION,TRUMP,SHOULD,ACTUALLY,THE HIGH,COST,DRUGS,THE NEW YORK TIMES,SITE,THOMAS J,AARON,JOSHUA,DRUG,PRICING,PROBLEM,MAY 14,DRUG ADMINISTRATION,COMMISSIONER,SCOTT,WORE,SOCKS,SKULLS,THE ANNOUNCEMENT,PRESIDENT,PRICES,THE ROSE GARDEN,LAST WEEK,GETTY,MAC,COSTS,BRITAIN,TICKET,THE LATEST,SUPERHERO MOVIE,SPAIN,IPAD PRO,SWITZERLAND,DO NOT,NEW YORK CITY,YOURE,SUFFERING,OVARIAN CANCER,RHEUMATOID ARTHRITIS,THE UNITED STATES,LEADING,MEDICINES,TWICE,SAME DRUGS,NATIONS,FACT,AMERICANS,ANGER,QUESTIONS,SPEND,SO MUCH,CROSSING THE BORDER,BUSES,FILL,CANADA,MEXICO,PERENNIAL,NEWS STORY,SURPRISE,DEVOTED,ADDRESS,PRESCRIPTION DRUGS,REVERSING,THE NARRATIVE,TOO MUCH,LITTLE,CASES,DOLLARS,FOREIGN,COUNTRY,HUNDREDS,IN AMERICA,PILL,INGREDIENTS,MADE IN,PLANT,MIND,POWERS,TAKING,ADVANTAGE,YET AGAIN,FREE RIDERS,FORCING,PATIENTS,TAXPAYERS,THE COST,GLOBAL,MEDICAL,INNOVATION,AMID,LONG LIST,PROPOSALS,PRESIDENTS,BIG IDEA,CUTTING,AT HOME,RAISING,IDEA,DIAGNOSIS,MISSES,THE MARK,SUGGESTS,POLICY,FREE MARKET,RECENT,REPORT,TRUMPS,COUNCIL OF ECONOMIC ADVISERS,VALUE,GOVERNMENT,MARKETS,POLITICAL,TRADE,NOTION,DETERMINED,OPEN,COMPETITION,PATENTS,GRANTS,MARKET,EXCLUSIVITY,EXIST,MANUFACTURERS,COMPETITORS,CHARGE,HIGH,LIMITED,PERIOD OF TIME,INVESTMENT,RESEARCH AND DEVELOPMENT,LAWS,REGULATIONS,PRIVATE,INSURERS,COVER,CANCER,CONSISTENT,PRICE,THE AMERICAN,HEALTH CARE SYSTEM,VIRTUALLY,PAYER,THE SYSTEM,MUST,NEGOTIATE,TERMS,COMPANIES,HEALTH,PLANS,LEVERAGE,THE DEPARTMENT OF,VETERANS,AFFAIRS,BULK,DISCOUNTS,ACQUISITION,CONTRACTS,EVIDENCE,CONSIDER,INDEED,AVERAGE,FOR SOME,HUMIRA,CLOSER,THE THRESHOLD,THE INSTITUTE FOR CLINICAL,ECONOMIC,REVIEW,INDEPENDENT,EVALUATOR,BUYING,COST EFFECTIVE,THE QUESTION,BEGIN,THE ANSWER,DEALS,CHANGE,INCENTIVES,FACE,DECISIONS,THIS IS NOT,NEW IDEA,STRONG,PATENT,PHARMACEUTICALS,THE TRADE,AUSTRALIA,SOUTH KOREA,DUE PROCESS,TRANSPARENCY,FORMULARY,DECADE,APPEAR,RAISED,CERTAINLY,LESS,STANCE,NAFTA,FUTURE,UNITED STATES TRADE,HALF,APPLY,ALREADY,THE MARKET,NUMBER,NEW MEDICINES,SUBJECT TO,POLICIES,BUILD,TRUE,CLEAR,BILATERAL TRADE,DRUG INDUSTRY,NO DOUBT,KNOWS,HARD,BELIEVE,PROMISE,REVENUES,INDUSTRY,STEEP,CUTS,THE TRUMP,ADMINISTRATION,MISSING,OPPORTUNITY,THE REAL,REASONS,AMERICAN,WE DO,GENEROUS,EUROPEAN NATIONS,SIMILAR,THE ONLY,CENTRAL,DISTINCT,OFFERS,DRUG PATENT,LIMITS,ABILITY,PUBLIC,PAYERS,EFFECTIVELY,COMBINATION,MEANS,WHATEVER,SEGMENT,BEAR,RATHER,BENCHMARK,THE DRUGS,THERAPEUTIC,ECONOMIC VALUE,UNDERLYING,BORNE,RISING,INSURANCE,FEWER,ABLE,AFFORD,CENTERS FOR MEDICARE MEDICAID,SPENDING,INCREASE,PERSON,DECIDE,WHETHER,THE CONVICTION,CAMPAIGN,CLAIMS,GOAL,REMAINS,LEARNING,THE BEST,FINDING,UNDERMINE,SUPPORT,MECHANISM,DETERMINE,REASONABLE,INNOVATIVE MEDICINES,LIVES,HEALTH CARE COSTS,SAVE,WORK,PRESENCE,PHARMACEUTICAL INDUSTRY,INVESTORS,SENIOR,FELLOW,THE COUNCIL ON FOREIGN,RELATIONS,FORMER UNITED STATES,AUTHOR,PARADOX,PROGRESS,THE WORLD,HEALTHIER,WORRISOME,THE PROGRAM,REGULATION,THERAPEUTICS,LAW,BRIGHAM AND WOMENS HOSPITAL,JOSHUA M SHARFSTEIN,PROFESSOR,PRACTICE,THE JOHNS HOPKINS BLOOMBERG,SCHOOL OF PUBLIC HEALTH,THE PUBLIC,HEALTH CRISIS,SURVIVAL,GUIDE,FOLLOW,SECTION,FACEBOOK,TWITTER,SIGN,TODAY,NEWSLETTER,HOME PAGE,C,EVENTS,INFORMATION,NAVIGATION,OPTIONS,